SCHEMBL4346458

SCHEMBL4346458

CCN(CC)C1=NC(=O)/C(=C/c2ccc(C(C)(C)C)cc2)S1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.56
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
NPC1 O15118 1/20 0.54
TNNI3 P19429 1/20 0.54
TNNT2 P45379 1/20 0.54
RAB9A P51151 1/20 0.54
GFER P55789 1/20 0.54
TNNC1 P63316 1/20 0.54
ALDH1A1 P00352 3/20 0.54
MAPT P10636 2/20 0.54
MAPK1 P28482 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
HTT P42858 1/20 0.51
POLB P06746 1/20 0.50
MYC P01106 1/20 0.44
MAX P61244 1/20 0.44
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4346461 1.00 ALOX5 (0.56) ALOX5MEN1KMT2ANPC1TNNI3
Bromide SCHEMBL4356600 0.99 ALOX5 (0.55) ALOX5MEN1KMT2ANPC1TNNI3
Bromide SCHEMBL4356597 0.99 ALOX5 (0.55) ALOX5MEN1KMT2ANPC1TNNI3
SCHEMBL4348545 0.85 RAB9A (0.58) ALOX5MEN1KMT2ANPC1TNNI3
SCHEMBL4348541 0.85 RAB9A (0.58) ALOX5MEN1KMT2ANPC1TNNI3
Bromide SCHEMBL4348013 0.84 RAB9A (0.56) ALOX5MEN1KMT2ANPC1TNNI3
Bromide SCHEMBL4348012 0.84 RAB9A (0.56) ALOX5MEN1KMT2ANPC1TNNI3
SCHEMBL4348992 0.84 MEN1 (0.56) ALOX5MEN1KMT2ANPC1TNNI3
SCHEMBL4348986 0.84 MEN1 (0.56) ALOX5MEN1KMT2ANPC1TNNI3
SCHEMBL4350157 0.83 POLB (0.71) ALOX5MEN1KMT2ANPC1TNNI3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 ALOX5 2623/4885MEN1 1725/4885KMT2A 3923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.